Polymorphism in Toll-Like Receptors and

Helicobacter pylori autoimmune gastritis flagellin A toll-like receptor 5 (TLR5) toll-like receptor 9 (TLR9)

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
10 May 2019
Historique:
received: 26 02 2019
revised: 03 05 2019
accepted: 07 05 2019
entrez: 15 5 2019
pubmed: 15 5 2019
medline: 15 5 2019
Statut: epublish

Résumé

Autoimmune atrophic gastritis (AAG) is associated with an increased risk of certain types of gastric cancer (GC).

Identifiants

DOI: 10.3390/cancers11050648 PMID: 31083432 PMC: PMC6562993
pubmed: 31083432
pii: cancers11050648
doi: 10.3390/cancers11050648
pmc: PMC6562993
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Centro di Riferimento Onoclogico
ID : CRO 5X1000_2010_MdS, Italy

Déclaration de conflit d'intérêts

The authors declare no conflict of interest

Références

J Clin Microbiol. 2003 Mar;41(3):976-80
pubmed: 12624018
Mol Microbiol. 2003 Jun;48(6):1579-92
pubmed: 12791140
Acta Pathol Microbiol Scand. 1965;64:31-49
pubmed: 14320675
J Exp Med. 2003 Oct 20;198(8):1147-56
pubmed: 14568977
Int J Med Microbiol. 2005 Jun;295(3):179-85
pubmed: 16044857
Nat Rev Drug Discov. 2006 Jun;5(6):471-84
pubmed: 16763660
J Immunol. 2006 Sep 1;177(5):2810-8
pubmed: 16920916
Hum Immunol. 2007 Nov;68(11):901-7
pubmed: 18082569
Vaccine. 2008 Mar 25;26(14):1731-6
pubmed: 18325643
Genome Biol. 2008;9(3):211
pubmed: 18341708
Gastroenterology. 2009 Jun;136(7):2247-57
pubmed: 19272387
Mol Cell Proteomics. 2009 Aug;8(8):1947-58
pubmed: 19470446
Infect Immun. 2010 Mar;78(3):1345-52
pubmed: 20038537
Cancer Sci. 2010 Apr;101(4):1059-66
pubmed: 20156214
Hum Mutat. 2010 Sep;31(9):1069-79
pubmed: 20652908
Eur J Immunol. 2010 Dec;40(12):3528-34
pubmed: 21072873
Mol Microbiol. 2010 Dec;78(5):1130-44
pubmed: 21091500
Clin Rev Allergy Immunol. 2012 Jun;42(3):269-78
pubmed: 21174235
J Immunol. 2011 May 1;186(9):5406-12
pubmed: 21451112
Int J Mol Med. 2011 Jul;28(1):115-9
pubmed: 21455558
Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2594-602
pubmed: 21994405
Biochem Biophys Res Commun. 2012 Sep 28;426(3):342-9
pubmed: 22940550
Helicobacter. 2012 Dec;17(6):411-6
pubmed: 23066970
Cell. 2013 Feb 14;152(4):703-13
pubmed: 23415221
Trends Immunol. 2013 Jun;34(6):282-9
pubmed: 23434408
PLoS One. 2013;8(4):e60327
pubmed: 23565226
Neoplasma. 2013;60(4):459-67
pubmed: 23581420
JAMA. 2013 May 8;309(18):1912-20
pubmed: 23652523
Nat Rev Gastroenterol Hepatol. 2013 Sep;10(9):529-41
pubmed: 23774773
Cancer Res. 2013 Dec 15;73(24):7232-42
pubmed: 24154872
Cell Host Microbe. 2013 Nov 13;14(5):571-81
pubmed: 24237702
Mol Med. 2014 Feb 28;20:57-71
pubmed: 24395566
Mol Cell. 2014 Apr 10;54(1):17-29
pubmed: 24657167
Front Neuroendocrinol. 2014 Aug;35(3):347-69
pubmed: 24793874
Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):1541-6
pubmed: 25605939
Inflamm Bowel Dis. 2015 Apr;21(4):854-61
pubmed: 25742401
Autoimmun Rev. 2015 Dec;14(12):1161-9
pubmed: 26275585
Acta Pharmacol Sin. 2015 Dec;36(12):1395-407
pubmed: 26592511
Sci Rep. 2016 Jan 12;6:18379
pubmed: 26755208
Biomed J. 2016 Feb;39(1):14-23
pubmed: 27105595
Oncogene. 2016 Dec 1;35(48):6262-6269
pubmed: 27157617
Oncotarget. 2016 Jun 21;7(25):37487-37497
pubmed: 27183918
Tumour Biol. 2016 Sep;37(9):12169-12180
pubmed: 27220495
Clin Transl Gastroenterol. 2016 Jul 21;7(7):e183
pubmed: 27441820
Int J Cancer. 2017 Feb 1;140(3):686-695
pubmed: 27756099
Autoimmun Rev. 2017 Feb;16(2):103-113
pubmed: 27988432
Scand J Gastroenterol. 2017 Apr;52(4):471-472
pubmed: 28040990
Sci Rep. 2017 Jan 20;7:40878
pubmed: 28106112
Curr Top Microbiol Immunol. 2017;400:169-193
pubmed: 28124154
Oncotarget. 2017 May 9;8(19):31016-31022
pubmed: 28404962
United European Gastroenterol J. 2017 Feb;5(1):37-44
pubmed: 28405320
Curr Microbiol. 2017 Jul;74(7):863-869
pubmed: 28444418
Infect Agent Cancer. 2017 Apr 27;12:22
pubmed: 28465717
Dig Liver Dis. 2017 Sep;49(9):947-956
pubmed: 28733178
PLoS Pathog. 2017 Aug 21;13(8):e1006574
pubmed: 28827825
Curr Treat Options Gastroenterol. 2018 Dec;16(4):561-569
pubmed: 30361856
Ann Gastroenterol. 2019 Jan-Feb;32(1):67-72
pubmed: 30598594
Clin Immunol Immunopathol. 1997 Sep;84(3):223-43
pubmed: 9281381

Auteurs

Valli De Re (V)

Immunopatologia e Biomarcatori Oncologici/Bio-proteomics facility, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy. vdere@cro.it.

Ombretta Repetto (O)

Immunopatologia e Biomarcatori Oncologici/Bio-proteomics facility, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy. orepetto@cro.it.

Mariangela De Zorzi (M)

Immunopatologia e Biomarcatori Oncologici/Bio-proteomics facility, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy. mdezorzi@cro.it.

Mariateresa Casarotto (M)

Immunopatologia e Biomarcatori Oncologici/Bio-proteomics facility, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy. mtcasarotto@cro.it.

Massimo Tedeschi (M)

Immunopatologia e Biomarcatori Oncologici/Bio-proteomics facility, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy. massimo.tedeschi@cro.it.

Paolo Giuffrida (P)

First Department of Internal Medicine, San Matteo Hospital Foundation, University of Pavia, 27100 Pavia, Italy. paolo.giuffrida01@universitadipavia.it.

Marco Vincenzo Lenti (MV)

First Department of Internal Medicine, San Matteo Hospital Foundation, University of Pavia, 27100 Pavia, Italy. marco.lenti@unipv.it.

Raffaella Magris (R)

Gastroenterologia Oncologica Sperimentale, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy. raffaella.magris@cro.it.

Gianmaria Miolo (G)

Preventive Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy. gmiolo@cro.it.

Cinzia Mazzon (C)

SSD Endocrinologia e malattie del metabolismo, Azienda per l'Assistenza Sanitaria 5 Friuli Occidentale, 33170 Pordenone, Italy. cinzia.mazzon@aas5.sanita.fvg.it.

Giorgio Zanette (G)

SSD Endocrinologia e malattie del metabolismo, Azienda per l'Assistenza Sanitaria 5 Friuli Occidentale, 33170 Pordenone, Italy. giorgio.zanette@aas5.sanita.fvg.it.

Lara Alessandrini (L)

Pathology Dept CRO Aviano, IRCCS, National Cancer Institute, 33081 Aviano, Italy. lara.alessandrini@aopd.veneto.it.
Department of Medicine (DIMED), Pathology, Azienda Ospedaliera di Padova, 35121 Padova, Italy. lara.alessandrini@aopd.veneto.it.

Vincenzo Canzonieri (V)

Pathology Dept CRO Aviano, IRCCS, National Cancer Institute, 33081 Aviano, Italy. vcanzonieri@cro.it.
Department of Medical, Surgical and Health Sciences, University of Trieste, 34127 Trieste, Italy. vcanzonieri@cro.it.

Laura Caggiari (L)

Immunopatologia e Biomarcatori Oncologici/Bio-proteomics facility, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy. lcaggiari@cro.it.

Stefania Zanussi (S)

Immunopatologia e Biomarcatori Oncologici/Bio-proteomics facility, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy. szanussi@cro.it.

Agostino Steffan (A)

Immunopatologia e Biomarcatori Oncologici/Bio-proteomics facility, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy. asteffan@cro.it.

Antonio Di Sabatino (A)

First Department of Internal Medicine, San Matteo Hospital Foundation, University of Pavia, 27100 Pavia, Italy. a.disabatino@smatteo.pv.it.

Renato Cannizzaro (R)

Gastroenterologia Oncologica Sperimentale, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy. rcannizzaro@cro.it.

Classifications MeSH